Osteoarthritis: Identification of a metabolomic biomarker for knee OA
Nature Reviews Rheumatology - Issue - nature.com s

The development of disease-modifying drugs for patients with osteoarthritis (OA) has been hampered somewhat by difficulties associated with the accurate assessment of therapy responses in clinical trials using radiographic techniques. For this reason, there is an urgent need for reliable, readily measurable biomarkers that can




More information